Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,117 across all filing types
Latest filing 2020-10-23 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
关于全资子公司完成工商注册并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of business registration and obtaining a business license for a wholly-owned subsidiary. It includes details about the subsidiary's registration, legal representative, registered capital, business scope, and related administrative information. There is no financial data, report, or detailed analysis present. The document is an official announcement about a corporate event rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, or Capital Update. It is a general regulatory announcement about corporate structure and registration, best classified under Regulatory Filings (RNS). The document length is short and focused on a specific corporate event, confirming it is not a full report or presentation.
2020-10-23 Chinese
关于公司控股股东部分股份质押的公告
Capital/Financing Update Classification · 100% confidence The document is a public announcement regarding the pledge of shares by the company's controlling shareholder. It details the number of shares pledged, the proportion of total shares, the pledgee, and the purpose of the pledge. It explicitly states it is an announcement about the shareholder's share pledge and includes no financial statements or detailed financial performance data. The document length is short (2015 characters) and it is clearly an announcement of a capital-related event (share pledge). This fits the category of Capital/Financing Update (CAP).
2020-10-23 Chinese
关于设立全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhuhai Sailong Pharmaceutical Co., Ltd. regarding the establishment of a wholly-owned subsidiary. It details the board meeting resolution, the subsidiary's registered capital, business scope, and the purpose and risks associated with the new subsidiary. There is no financial data, no mention of a report being attached or published, and no indication of a regulatory filing or certification. The content is about a corporate action related to capital investment and company structure expansion, which fits best under Capital/Financing Update (CAP). The document length is short and focused on this announcement, not a full report or financial statement.
2020-10-19 Chinese
第二届董事会第二十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 28th meeting of the second board of directors of Zhuhai Sailong Pharmaceutical Co., Ltd. It details the meeting date, attendance, and the approval of establishing a wholly-owned subsidiary. The document is an official disclosure of board decisions, not a full report or financial statement. It does not contain financial data or detailed management discussion but focuses on board meeting resolutions. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA. No officer certification or regulatory filing is indicated, so RNS is not appropriate.
2020-10-19 Chinese
2020年第三季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast (业绩预告) for the third quarter of 2020, providing estimated financial results such as net profit and earnings per share for the period from January 1 to September 30, 2020, and specifically for the third quarter (July 1 to September 30, 2020). It explicitly states that the forecast is unaudited and is preliminary, with final data to be disclosed in the official third quarter report. The document is short (1543 characters) and serves as an earnings preview rather than a full financial report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly/periodical financial results with key highlights only. 9M 2020
2020-10-14 Chinese
关于公司股东部分股份质押延期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the extension of a shareholder's stock pledge (质押延期公告). It details the shareholder's pledged shares, the extension of the pledge period, and related information about the shareholder's stock pledge status. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about a shareholder's capital/financing activity (stock pledge extension), which fits best under Capital/Financing Update (CAP). The document length is short (2253 characters), and it is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2020-09-10 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.